PREDICTORS OF FEBRILE NEUTROPAENIA AND EARLY TREATMENT CESSATION DUE TO TOXICITY IN MEN RECEIVING Q3 WEEKLY DOCETAXEL FOR METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC) Conference Paper uri icon

authors

  • Hamid, Anis
  • Wilson, K
  • Pezaro, C
  • Lee, M
  • Tran, B
  • Bergin, A
  • Gan, C
  • Tamjid, B
  • Campbell, A
  • Stewart, J
  • Vincent, A
  • Weickhardt, A

publication date

  • July 1, 2016